Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents

Nanomedicine

Volumn 10, Issue 9, 2015, Pages 1391-1406

  Zohra, Fatema Tuj ^a   Medved, Mikhail ^a   Lazareva, Nina ^a   Polyak, Boris ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

endothelial integrity and functional potency; gene expression; in stent restenosis; magnetic cell delivery; magnetic nanoparticles; primary endothelial cells; re endothelialization

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; COLLAGEN TYPE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENTACTIN; LAMININ; MAGNETIC NANOPARTICLE; NITRIC OXIDE; PROSTACYCLIN; PROTEIN C; PROTEIN S; PROTEOHEPARAN SULFATE; THROMBOMODULIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 1; NANOPARTICLE;

ANIMAL CELL; AORTA ENDOTHELIUM; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION ASSAY; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MAGNETIC FIELD; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TARGET CELL; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR STENT; ANIMAL; CELL ADHESION; CELL CULTURE; CYTOLOGY; MAGNETISM; METABOLISM; STENT; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; MAGNETICS; NANOPARTICLES; RATS; STENTS;

EID: 84929869666     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.13     Document Type: Article

References (48)

1. Writing Group M, Lloyd-Jones D, Adams RJ et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121(7), e46-e215 (2010).
2. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125(1), e2-e220 (2012).
3. Flammer AJ, Anderson T, Celermajer DS et al. The assessment of endothelial function: from research into clinical practice. Circulation 126(6), 753-767 (2012).
4. Pauletto P, Sartore S, Pessina AC. Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis. Clin. Sci. 87(5), 467-479 (1994).
5. Scott NA. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv. Drug Deliv. Rev. 58(3), 358-376 (2006).
6. Er OB, Ma X, Simard T, Pourdjabbar A, Hibbert B. Pathogenesis of neointima formation following vascular injury. Cardiovasc. Hematol. Disord. Drug Targets 11(1), 30-39 (2011).
7. Asahara T, Chen D, Tsurumi Y et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 94(12), 3291-3302 (1996).
8. Hedman M, Hartikainen J, Syvanne M et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107(21), 2677-2683 (2003).
9. Losordo DW, Isner JM, Diaz-Sandoval LJ. Endothelial recovery: the next target in restenosis prevention. Circulation 107(21), 2635-2637 (2003).
10. Polyak B, Fishbein I, Chorny M et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc. Natl Acad. Sci. USA 105(2), 698-703 (2008).
11. Finn AV, Gold HK, Tang A et al. A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J. Vasc. Res. 39(5), 414-425 (2002).
12. Fishbein I, Alferiev I, Bakay M et al. Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries. Circulation 117(16), 2096-2103 (2008).
13. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99(6), 2034-2040 (1984).
14. Macdonald C, Friedman G, Alamia J, Barbee K, Polyak B. Time-varied magnetic field enhances transport of magnetic nanoparticles in viscous gel. Nanomedicine 5(1), 65-76 (2010).
15. Johnson B, Toland B, Chokshi R, Mochalin V, Koutzaki S, Polyak B. Magnetically responsive paclitaxel-loaded biodegradable nanoparticles for treatment of vascular disease: preparation, characterization and in vitro evaluation of anti-proliferative potential. Curr. Drug Deliv. 7(4), 263-273 (2010).
16. Adams CF, Rai A, Sneddon G, Yiu HH, Polyak B, Chari DM. Increasing magnetite contents of polymeric magnetic particles dramatically improves labeling of neural stem cell transplant populations. Nanomedicine 11(1), 19-29 (2014).
17. Macdonald C, Barbee K, Polyak B. Force dependent internalization of magnetic nanoparticles results in highly loaded endothelial cells for use as potential therapy delivery vectors. Pharm. Res. 29(5), 1270-1281 (2012).
18. Arnaoutova I, George J, Kleinman HK, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12(3), 267-274 (2009).
19. Arnaoutova I, Kleinman HK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat. Protoc. 5(4), 628-635 (2010).
20. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 23(2), 168-175 (2003).
21. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265(5595), 625-626 (1977).
22. Snow AD, Bolender RP, Wight TN, Clowes AW. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am. J. Pathol. 137(2), 313-330 (1990).
23. Leon MB, Baim DS, Popma JJ et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N. Engl. J. Med. 339(23), 1665-1671 (1998).
24. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57(5), 946-955 (1981).
25. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl Acad. Sci. USA 88(11), 4651-4655 (1991).
26. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83(5), 1774-1777 (1989).
27. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78(2), 225-230 (1996).
28. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332(6163), 411-415 (1988).
29. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol. Sci. 13(3), 103-108 (1992).
30. Rautureau Y, Schiffrin EL. Endothelin in hypertension: an update. Curr. Opin. Nephrol. Hyperten. 21(2), 128-136 (2012).
31. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92(9), 2426-2431 (1995).
32. Yoon MH, Reriani M, Mario G et al. Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int. J. Cardiol. 168(2), 1316-1321 (2013).
33. Cheng K, Li TS, Malliaras K, Davis DR, Zhang Y, Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ. Res. 106(10), 1570-1581 (2010).
34. Cheng K, Malliaras K, Li TS et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 21(6), 1121-1135 (2012).
35. Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc. Res. 53(2), 313-325 (2002).
36. Gils A, Declerck PJ. Plasminogen activator inhibitor-1. Curr. Med. Chem. 11(17), 2323-2334 (2004).
37. Frazier WA. Thrombospondins. Curr. Opin. Cell Biol. 3(5), 792-799 (1991).
38. Asch AS, Tepler J, Silbiger S, Nachman RL. Cellular attachment to thrombospondin. Cooperative interactions between receptor systems. J. Biol. Chem. 266(3), 1740-1745 (1991).
39. Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl Acad. Sci. USA 88(11), 5026-5030 (1991).
40. Majack RA, Cook SC, Bornstein P. Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc. Natl Acad. Sci. USA 83(23), 9050-9054 (1986).
41. Yabkowitz R, Mansfield PJ, Ryan US, Suchard SJ. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. J. Cell. Physiol. 157(1), 24-32 (1993).
42. Tuszynski GP, Rothman VL, Murphy A, Siegler K, Knudsen KA. Thrombospondin promotes platelet aggregation. Blood 72(1), 109-115 (1988).
43. Dixit VM, Haverstick DM, O'Rourke KM et al. A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc. Natl Acad. Sci. USA 82(10), 3472-3476 (1985).
44. Chen D, Asahara T, Krasinski K et al. Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. Circulation 100(8), 849-854 (1999).
45. Pallero MA, Talbert Roden M, Chen YF et al. Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis. J. Vasc. Res. 47(4), 309-322 (2010).
46. Mcbain SC, Griesenbach U, Xenariou S et al. Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology 19(40), 405102 (2008).
47. Jenkins SI, Pickard MR, Granger N, Chari DM. Magnetic nanoparticle-mediated gene transfer to oligodendrocyte precursor cell transplant populations is enhanced by magnetofection strategies. ACS Nano 5(8), 6527-6538 (2011).
48. Pickard M, Chari D. Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields. Nanomedicine 5(2), 217-232 (2010).